Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,994 public trials 1,209 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Active, Not Recruiting

A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)

NCT06346067

Conditions
Advanced or Metastatic NRAS-mutant Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • Mayo Clinic - Arizona Phoenix, Arizona, United States
  • University of California, San Francisco San Francisco, California, United States
  • The Melanoma and Skin Care Institute Englewood, Colorado, United States
  • Mayo Clinic - Florida Jacksonville, Florida, United States
View all 59 locations
View Trial Details
Active, Not Recruiting

A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations

NCT05907304

Conditions
Advanced or Metastatic Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +34 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • Florida Cancer Specialists - St. Petersburg St. Petersburg, Florida, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid Tumors

NCT04336241

Conditions
Breast Diseases, Breast Neoplasms, Cancer, +25 more
Locations
  • Hospital Universitario d'Hebron Barcelona, Spain
  • Hospital Universitario HM Sanchinarro Madrid, Spain
  • Hospital Clinico de Valencia Valencia, Spain
  • The Clatterbridge Cancer Centre NHS Foundation Trust Bebington, Merseyside, United Kingdom
View Trial Details
Active, Not Recruiting

Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors

NCT01824875

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +23 more
Locations
  • Kaiser Anaheim Medical Center Anaheim, California, United States
  • Kaiser Permanente-Deer Valley Medical Center Antioch, California, United States
  • Kaiser Permanente Medical Group - Baldwin Park Baldwin Park, California, United States
  • Kaiser Foundation Hospital Bellflower, California, United States
View all 323 locations
View Trial Details
Active, Not Recruiting

High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma

NCT00003641

Conditions
Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States
View all 533 locations
View Trial Details
Active, Not Recruiting

A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001)

NCT04471727

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +26 more
Locations
  • Cedar-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions